1. Preface to special issue (Commercial Developments in Purinergic Signalling)

   • Geoffrey Burnstock

   Editorial 24 November 2011 Pages: 1 - 1

2. In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization

   • Anthony P. Ford

   Original Article Open access 18 November 2011 Pages: 3 - 26

   

3. Measurement of purine release with microelectrode biosensors

   • Nicholas Dale
   • Bruno G. Frenguelli

   Original Article 18 November 2011 Pages: 27 - 40

   

4. P2X receptor antagonists for pain management: examination of binding and physicochemical properties

   • Rebecca J. Gum
   • Brian Wakefield
   • Michael F. Jarvis

   Original Article 16 November 2011 Pages: 41 - 56

   

5. ATPace™: injectable adenosine 5′-triphosphate

   • Amir Pelleg
   • Steven P. Kutalek
   • David Benditt

   Orignal Article 06 November 2011 Pages: 57 - 60

6. Using antibodies against P2Y and P2X receptors in purinergic signaling research

   • Dovrat Brass
   • Melanie R. Grably
   • Alon Meir

   Original Article Open access 16 November 2011 Pages: 61 - 79

   

7. The impact of commercially available purinergic ligands on purinergic signalling research

   • J. R. Flanaghan
   • S. J. Roome

   Original Article 27 October 2011 Pages: 81 - 89

   

8. Partial adenosine A1 receptor agonists for cardiovascular therapies

   • Barbara E. Albrecht-Küpper
   • Kirsten Leineweber
   • Peter G. Nell

   Original Article 12 November 2011 Pages: 91 - 99

   

9. Development of a comprehensive set of P2 receptor pharmacological research compounds

   • R. A. Felix
   • S. Martin
   • D. J. Crawford

   Original Article 04 November 2011 Pages: 101 - 112